SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: VLAD who wrote (10246)6/29/1998 6:41:00 PM
From: VLAD  Read Replies (1) of 23519
 
I understand that Vivus will report the costs of the rental sales reps as a one time charge. If this is true then something will soon be changing.

These are my recommendations to get the ball rolling in the right direction:

1)Announce a further stock buy back of about $10,000,000.00--these prices will not last long and profitability should return in the next quarter. Vivus still has enough cash to do this.
2)Announce the elimination of the new sales force and announce a joint partnership with a large pharmaceutical. Vivus can leave all the sales efforts and advertising to the likes of Merck or J&J for a percentage of domestic sales. This would be a big plus for everyone involved.
3)Sell the rights to Japan ASAP as it is currently "dead" money.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News